Osimertinib treatment for advanced non-small cell lung cancer increases survival rates, study finds Patients treated with osimertinib had an average of 39.1 months of progression-free survival, compared with 5.6 months in those given placebo.…
Management of Waldenstrom’s macroglobulinaemia An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options.… Supported content
Why we are helping patients with lung cancer symptoms self-refer for a chest X-ray Pharmacies in Leeds are helping to diagnose lung cancer earlier by piloting a service that allows patients with red-flag symptoms to refer themselves to hospital for testing.…
More than 60 community pharmacies access cancer red-flag symptom card scheme Exclusive: The ‘Not normal for you?’ scheme enables pharmacists to identify patient behaviours that may signal cancer and refer patients for red-flag symptoms.…
Community pharmacy pilot to focus on spotting patients with early signs of lung cancer Four sites in England will focus on lung cancer as part of the ‘NHS supporting early diagnosis of cancer’ pilot service.…
First Scottish consultant pharmacist appointed Jennifer Laskey has been appointed as a consultant cancer pharmacist by NHS Greater Glasgow and Clyde.…
First referrals for ‘red flag’ cancer symptoms made under community pharmacy pilot Exclusive: It has been confirmed that 12 pharmacies in the East of England are now delivering the pilot and the first referral to specialist cancer services has been made.…
Cannabidiol as a chemotherapy adjunct in cancer treatment An overview of the potential of cannabidiol in combination with standard chemotherapy drugs for both the treatment of cancer and management of chemotherapy side effects.…
Expanded genetic profiling could guide cancer treatment, study finds Researchers analysed whole-genome data with data from the NHS, revealing genetic changes in cancers that may affect survival rates and patient outcomes.…
Prostate cancer: recognition and diagnosis An overview of prostate cancer for pharmacists, including early detection and prevention, testing and diagnosis.…
